BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15015784)

  • 1. Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors.
    Fiorillo A; Maggi G; Greco N; Migliorati R; D'Amico A; De Caro MD; Sabbatino MS; Buffardi F
    J Neurooncol; 2004 Jan; 66(1-2):179-85. PubMed ID: 15015784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
    Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
    J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
    Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
    AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
    Ashby LS; Shapiro WR
    J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
    deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED
    Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
    Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
    Gridelli C; D'Aprile M; Palmeri S; Curcio C; Rossi A; Gebbia V; Veltri E; Pepe R; Pistillucci G; Bianco AR
    Am J Clin Oncol; 1996 Dec; 19(6):589-91. PubMed ID: 8931678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors.
    Lippens RJ
    Pediatr Hematol Oncol; 1999; 16(2):131-9. PubMed ID: 10100273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
    Walter AW; Gajjar A; Ochs JS; Langston JW; Sanford RA; Kun LE; Heideman R
    Med Pediatr Oncol; 1998 Jan; 30(1):28-33. PubMed ID: 9371386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
    Korones DN; Smith A; Foreman N; Bouffet E
    Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary chemotherapy issues for children with brainstem gliomas.
    Allen JC; Siffert J
    Pediatr Neurosurg; 1996; 24(2):98-102. PubMed ID: 8841080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide-containing regimens with autologous bone marrow transplantation in children with malignant brain tumors.
    Busca A; Miniero R; Besenzon L; Cordero di Montezemolo L; Cenni M; Fagioli F; Sandri A; Vassallo E; Ricardi U; Madon E
    Childs Nerv Syst; 1997; 13(11-12):572-7. PubMed ID: 9454971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma.
    Tonder M; Weller M; Eisele G; Roth P
    Chemotherapy; 2014; 60(5-6):375-8. PubMed ID: 26496463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
    Scopece L; Franceschi E; Cavallo G; Paioli A; Paioli G; Conforti R; Palmerini E; Berzioli C; Spagnolli F; Esposti RD; Crinò L
    J Neurooncol; 2006 Sep; 79(3):299-305. PubMed ID: 16645720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
    Potamianou A; Androulakis N; Papakotoulas P; Toufexi H; Latoufis C; Kouroussis C; Christofilakis C; Xenidis N; Georgoulias V; Polyzos A
    Oncology; 2005; 69(4):348-53. PubMed ID: 16293974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
    Williams PC; Henner WD; Roman-Goldstein S; Dahlborg SA; Brummett RE; Tableman M; Dana BW; Neuwelt EA
    Neurosurgery; 1995 Jul; 37(1):17-27; discussion 27-8. PubMed ID: 8587686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
    Chamberlain MC
    Pediatr Neurol; 2001 Feb; 24(2):117-21. PubMed ID: 11275460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.